Jeremy Howard Lewin, MD, of Peter MacCallum Cancer Center in East Melbourne, Australia, and colleagues conducted this retrospective study to assess disease sub-stage specific PET surveillance in a cohort of 86 patients with resected stage III melanoma. {read more here}